Alumis ALMS
NASDAQ ALMS
$11.16 -0.20 (-1.76%)
As of: Sep 4, 2026 · 2:40 PM EDT

Alumis (ALMS) Change in Acquisitions & Divestments (2023 - 2025)

Alumis (ALMS) posted quarterly Change in Acquisitions & Divestments of $142.5 million for Q4 2025, up 65.73% year-over-year from $86.0 million in Q4 2024, and down 11.55% quarter-over-quarter from $161.1 million in Q3 2025.

Analysis

Alumis (ALMS) Change in Acquisitions & Divestments (2023 - 2025) Analysis & Trends

Alumis (ALMS) has reported Change in Acquisitions & Divestments for 3 consecutive years, with $142.5 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Change in Acquisitions & Divestments rose 65.73% year-over-year to $142.5 million; the TTM figure through Dec 2025 stood at $448.0 million (up 249.96% YoY), while the FY2025 annual figure was $448.0 million, up 249.96% from the prior year.
  • Change in Acquisitions & Divestments fell to $142.5 million in Q4 2025 per ALMS's latest filing, from $161.1 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $161.1 million in Q3 2025 and bottomed at $1.0 million in Q1 2024.
  • Historically, Change in Acquisitions & Divestments has averaged $65.1 million across 3 years, with a median of $64.0 million in 2025.
  • On a YoY basis, Change in Acquisitions & Divestments climbed as much as 6300.0% in 2025 and fell as far as 65.73% in 2025.
  • Alumis' Change in Acquisitions & Divestments stood at $9.8 million in 2023, then soared by 782.05% to $86.0 million in 2024, then surged by 65.73% to $142.5 million in 2025.
  • Business Quant data shows ALMS's Change in Acquisitions & Divestments at $142.5 million in Q4 2025, $161.1 million in Q3 2025, and $80.3 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.74 Bn 130.89 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.52 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.04 Bn 52.91 Bn 52.00 Mn
5 Revolution Medicines 44.06 Bn 44.06 Bn -
6 BeOne Medicines 39.98 Bn 34.88 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.46 Bn 32.15 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Alumis 1.43 Bn 923.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 142.53 Mn
Sep 30, 2025 161.15 Mn
Jun 30, 2025 80.27 Mn
Mar 31, 2025 64.00 Mn
Dec 31, 2024 86.00 Mn
Sep 30, 2024 34.00 Mn
Jun 30, 2024 7.00 Mn
Mar 31, 2024 1.00 Mn
Sep 30, 2023 9.75 Mn